Watching Veru; Traders Circulate Analyst Comments Suggesting Co Could See A Take Out From Large Pharma Due To Effectivr GLP-1; Gives It An Outperform Rating And $3 PT
Watching Veru; Traders Circulate Analyst Comments Suggesting Co Could See A Take Out From Large Pharma Due To Effectivr GLP-1; Gives It An Outperform Rating And $3 PT
觀看 Veru;交易員散佈分析師的評論,暗示由於有效的 GLP-1,該公司可能會從大型製藥公司中脫穎而出;給予其跑贏大盤評級和3美元
Watching Veru; Traders Circulate Analyst Comments Suggesting Co Could See A Take Out From Large Pharma Due To Effectivr GLP-1; Gives It An Outperform Rating And $3 PT
觀看 Veru;交易員散佈分析師的評論,暗示由於有效的 GLP-1,該公司可能會從大型製藥公司中脫穎而出;給予其跑贏大盤評級和3美元